Our commitment to advancing cancer care and molecular research spans more than a decade. We explore ways to improve patient care, enhance the healthcare delivery system, and transform precision medicine into reality.
Scientific and Medical Publications
We conduct and publish volumes of research to fulfill the promise of precision medicine and improve the lives of patients with cancer. Since 2011, our medical and scientific experts have authored more than 100 manuscripts in peer-reviewed medical and scientific journals, and more than 250 abstracts, posters, and presentations at leading industry conferences and symposiums that expound on our innovative platforms and technologies.
Caris Life Sciences offers unparalleled precision medicine services that are designed to maximize the chances of success for clinical trials and address many patient accrual challenges facing biopharma partners in the world of precision medicine.
The Caris Life Sciences Observational Studies initiative is a collection of multicenter, prospective and observational outcomes tracking studies designed to collect data on the demographics, presentation, diagnosis, treatment, resource use, and outcomes of eligible patients who previously have undergone Caris Molecular Intelligence tumor profiling for treatment of solid tumor cancer. Participation guidelines and study protocols have been reviewed and approved by an independent Institutional Review Board.
The information collected by the Observational Studies initiative includes detailed molecular profiling information about a participating patient’s disease, treatment plan, and response. This information represents statistically correlated data to inform physicians about the efficacy of various chemotherapies and biological therapies. The data is intended to demonstrate the clinical utility of tumor profiling and to assist physicians in the delivery of precision medicine to their patients
Caris Molecular Intelligence® is Patent Pending and is covered by one or more U.S. Patents: